All Videos Channels
  1. Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    3
  3. BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    9
  10. September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    299
  11. Desperately seeking Medical Expertise (samples.. )

    Desperately seeking Medical Expertise (samples.. )

    24
  13. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  14. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    21
  15. Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    8
  16. Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    7
  17. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    12
  18. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    6
  19. Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    8
  20. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    3
  21. In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    6
  22. BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    6
  23. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    19
  24. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    15
  25. Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    5